SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-007408
Filing Date
2015-08-14
Accepted
2015-08-14 16:01:08
Documents
10
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q kura-10q_20150630.htm 10-Q 1098581
2 EX-31.1 kura-ex311_7.htm EX-31.1 14657
3 EX-31.2 kura-ex312_8.htm EX-31.2 14382
4 EX-32.1 kura-ex321_9.htm EX-32.1 8255
  Complete submission text file 0001564590-15-007408.txt   4224087

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT kura-20150630.xml EX-101.INS 733022
6 XBRL TAXONOMY EXTENSION SCHEMA kura-20150630.xsd EX-101.SCH 41880
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kura-20150630_cal.xml EX-101.CAL 36817
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kura-20150630_def.xml EX-101.DEF 138376
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE kura-20150630_lab.xml EX-101.LAB 299689
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kura-20150630_pre.xml EX-101.PRE 235630
Mailing Address 11119 N. TORREY PINES ROAD, STE 125 LA JOLLA CA 92037
Business Address 11119 N. TORREY PINES ROAD, STE 125 LA JOLLA CA 92037 (858) 500-8800
Kura Oncology, Inc. (Filer) CIK: 0001422143 (see all company filings)

IRS No.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-53058 | Film No.: 151055558
SIC: 2834 Pharmaceutical Preparations